GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) » Definitions » Additional Paid-In Capital

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Wanbangde Pharmaceutical Holding Group Co Additional Paid-In Capital?


Wanbangde Pharmaceutical Holding Group Co's quarterly additional paid-in capital increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥297 Mil) but then stayed the same from Dec. 2023 (¥297 Mil) to Mar. 2024 (¥0 Mil).

Wanbangde Pharmaceutical Holding Group Co's annual additional paid-in capital stayed the same from Dec. 2021 (¥291 Mil) to Dec. 2022 (¥291 Mil) but then increased from Dec. 2022 (¥291 Mil) to Dec. 2023 (¥297 Mil).


Wanbangde Pharmaceutical Holding Group Co Additional Paid-In Capital Historical Data

The historical data trend for Wanbangde Pharmaceutical Holding Group Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanbangde Pharmaceutical Holding Group Co Additional Paid-In Capital Chart

Wanbangde Pharmaceutical Holding Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 227.41 305.67 291.39 291.39 297.37

Wanbangde Pharmaceutical Holding Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 291.39 - 297.37 -

Wanbangde Pharmaceutical Holding Group Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Wanbangde Pharmaceutical Holding Group Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Wanbangde Pharmaceutical Holding Group Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Business Description

Traded in Other Exchanges
N/A
Address
Dongliang Road 1688, Zhili Town, Zhejiang, Huzhou, CHN, 313008
Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.
Executives
Zhao Shou Ming Directors, executives
Wang Tian Fang Director
Li Rong Fang Supervisors
Zhu Jian Xin Directors, executives
Yang Jin Rong Executives
Song Tie He Directors, executives
Song Jian Hua Executives
Pan Yun Chu Director
Yu Ju Ming Executives
Yang Mei Gen Executives
Tao Jian Feng Supervisors
Qian Shu Sheng Executives
Shen Bai Ming Director
Xu Yin Sheng Director
Shuang Zhi Wei Executives

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Headlines

No Headlines